KemPharm, Inc. (NASDAQ: KMPH) announced that the New Drug Application (NDA) for KP201/APAP, its investigational drug candidate for the short-term ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE